Strategic Shifts and Acquisitions in Novartis

The chapter explores Novartis' recent strategic moves in the pharmaceutical industry, including restructuring, acquisitions, and refocusing on cancer immunology. It discusses the company's financial performance, patent challenges, and positive outlook under new leadership.